BABA Up, PGEN Down: Upside, Downside Movers in the Morning

Avatar photo Doug Kass on November 2, 2026

– $INO +262% (FDA grants accelerated approval to VOCERYQ to reduce surgery frequency in adults with recurrent respiratory papillomatosis)

– $PERI +31% (agrees to be acquired by Affle for $11.70 a share in cash, valuing the deal at about $420M)

– $IDXX +7.8% (Q3 beat and FY revenue and EPS outlooks were raised, outweighing a slightly lower margin range)

– $BABA +3.3% (China adds liquidity through a 100B-yuan swap facility, while reports point to BABA support for AAPL’s China AI rollout)

– $SKHY +3.2%, MU +1.1%, WDC +1.0%, SMTC +1.3% (memory and connectivity names rebound from Friday’s chip rout as Deutsche Bank turns bullish on US technology)

– $GFI +3.1%, AG +1.7%, HL +1.9% (gold and silver miners rebound as precious-metal prices recover)

– $RIVN +3.0% (UBS upgrades to Buy on valuation after the recent selloff)

– $CRWD +2.6% (Deutsche Bank upgrades to Buy)

– $EL +2.3% (Q1 beat with strong margin expansion and the FY sales, margin and EPS outlook raised)

– $AU +2.2% (TD Cowen initiates at Buy as gold rebounds)

– $FORM +1.7% (Freedom Capital upgrades to Buy after record Q3 results and the recent pullback)

– $CRWV +1.4%, BE +1.2%, $VRT +1.3% (AI-infrastructure names rebound with technology after the sharp three-week selloff)

Downside

– $KPTI -69% (files Chapter 11 and names Ayrmid as lead bidder in a court-supervised sale process)

– $PGEN -28% (falls on new RRP competition after the FDA approves INO’s VOCERYQ)

– $KOS -9.2% (Q3 profit and revenue missed expectations as crude prices retreat)

– $CHKP -6.3% (Q3 revenue slipped and missed expectations as management said the recovery is taking longer than anticipated)

– $EQNR -2.9%, $OXY -2.0%, $APA -1.9%, $XOM -1.3%, $CVX -1.1% (oil producers fall as crude drops nearly 4% on renewed US-Iran diplomacy)

Upgrades, Downgrades and New Research Coverage

Avatar photo Chris Versace on October 15, 2026

Upgrades:

ArcelorMittal ($MT) upgraded to Overweight from Neutral at JPMorgan

Array Technologies ($ARRY) upgraded to Outperform from Neutral at Mizuho, Target: $5

Bank of America ($BAC) upgraded to Outperform from Neutral at Baird, Target: $62

BorgWarner ($BWA) upgraded to Buy from Neutral at BofA, Target: $85

Brighthouse Financial ($BHF) upgraded to Neutral from Underweight at JPMorgan, Target: $55

CarMax ($KMX) upgraded to Buy from Underperform at BofA, Target: $65

Casey’s General Stores ($CASY) upgraded to Outperform from Sector Perform at RBC Capital, Target: $825

Cemex ($CX) upgraded to Buy from Neutral at Citi, Target: $12

Crocs ($CROX) upgraded to Overweight from Equal Weight at Barclays, Target: $139

Fortrea ($FTRE) upgraded to Buy from Hold at Deutsche Bank, Target: $25

Lithium Americas ($LAC) upgraded to Speculative Buy from Hold at Canaccord

Quantinuum ($QNT) upgraded to Overweight from Equal Weight at Morgan Stanley, Target: $62

Scotts Miracle-Gro ($SMG) upgraded to Buy from Neutral at UBS, Target: $70

Walmart ($WMT) upgraded to Buy from Hold at Deutsche Bank, Target: $136

Zions Bancorp ($ZION) upgraded to Outperform from Neutral at Baird, Target: $75

Downgrades:

Albertsons ($ACI) downgraded to Neutral from Overweight at JPMorgan, Target: $14

Albertsons ($ACI) downgraded to Neutral from Buy at Goldman Sachs, Target: $13

Align Technology ($ALGN) downgraded to Neutral from Outperform at Baird, Target: $162

Cirrus Logic ($CRUS) downgraded to Sector Weight from Overweight at KeyBanc

Dauch ($DCH) downgraded to Underperform from Buy at BofA, Target: $5

Envista ($NVST) downgraded to Neutral from Outperform at Baird, Target: $26

Par Pacific ($PARR) downgraded to Neutral from Buy at Goldman Sachs, Target: $94

Spotify ($SPOT) downgraded to Hold from Buy at StoneX

ZTO Express ($ZTO) downgraded to Neutral from Buy at Goldman Sachs, Target: $22

New research coverage

AngloGold Ashanti ($AU) initiated with a Buy at Goldman Sachs, Target: $104

Antero Resources ($AR) initiated with a Sector Outperform at Scotiabank, Target: $46

APA Corp. ($APA) initiated with a Sector Perform at Scotiabank, Target: $44

Black Hills ($BKH) initiated with a Buy at Jefferies, Target: $87

Bright Minds Biosciences ($DRUG) initiated with an Outperform at Wolfe Research, Target: $150

CAMP4 Therapeutics ($CAMP) initiated with a Buy at Needham, Target: $8

Chord Energy ($CHRD) initiated with a Sector Outperform at Scotiabank, Target: $192

CNX Resources (CNX) initiated with a Sector Perform at Scotiabank, Target: $34

Crescent Energy ($CRGY) initiated with a Sector Outperform at Scotiabank, Target: $18

CRISPR Therapeutics ($CRSP) initiated with a Neutral at UBS, Target: $52

Devon Energy ($DVN) initiated with a Sector Outperform at Scotiabank, Target: $61

Diamondback Energy ($FANG) initiated with a Sector Outperform at Scotiabank, Target: $250

Digital Turbine ($APPS) resumed with a Buy at Roth Capital, Target: $19

Eloxx Pharmaceuticals ($ELOX) initiated with an Overweight at Cantor Fitzgerald

EOG Resources ($EOG) initiated with a Sector Perform at Scotiabank, Target: $144

EQT Corporation ($EQT) initiated with a Sector Perform at Scotiabank, Target: $54

Establishment Labs ($ESTA) initiated with a Buy at Stifel, Target: $85

Fidelity National Information Services ($FIS) resumed with a Buy at BofA, Target: $42

First Financial Bankshares ($FFIN) initiated with a Market Perform at Raymond James

Fiserv ($FISV) resumed with an Underperform at BofA, Target: $48

Global Payments ($GPN) resumed with a Buy at BofA, Target: $114

Gold Fields ($GFI) initiated with a Neutral at Goldman Sachs, Target: $38

Gulfport Energy ($GPOR) initiated with a Sector Outperform at Scotiabank, Target: $217

HawkEye 360 ($HAWK) initiated with an Overweight at Piper Sandler, Target: $22

Hemab Therapeutics ($COAG) initiated with an Overweight at JPMorgan, Target: $70

Infinity Natural Resources ($INR) initiated with a Sector Outperform at Scotiabank, Target: $17

Magnolia Oil & Gas ($MGY) initiated with a Sector Outperform at Scotiabank, Target: $31

Matador Resources ($MTDR) initiated with a Sector Perform at Scotiabank, Target: $59

MGE Energy ($MGEE) initiated with a Neutral at JPMorgan, Target: $76

Murphy Oil ($MUR) initiated with a Sector Perform at Scotiabank, Target: $41

Netflix ($NFLX) assumed with a Buy at Jefferies, Target: $85

Northern Oil and Gas ($NOG) initiated with a Sector Perform at Scotiabank, Target: $27

onsemi ($ON) initiated with a Buy at StoneX, Target: $110

Ovid Therapeutics ($OVID) initiated with an Outperform at Wolfe Research, Target: $5

Permian Resources ($PR) initiated with a Sector Outperform at Scotiabank, Target: $29

Rapport Therapeutics ($RAPP) initiated with an Outperform at Wolfe Research, Target: $50

Rapport Therapeutics ($RAPP) initiated with a Buy at UBS, Target: $71

Redwire ($RDW) initiated with a Neutral at Piper Sandler, Target: $11

Shift4 Payments ($FOUR) resumed with a Neutral at BofA, Target: $42

Sight Sciences ($SGHT) initiated with a Buy at H.C. Wainwright, Target: $14

SM Energy ($SM) initiated with a Sector Perform at Scotiabank, Target: $39

Solid Biosciences ($SLDB) initiated with a Buy at UBS, Target: $20

Spectrum Brands ($SPB) resumed with a Buy at UBS, Target: $97

Suja Life ($SUJA) initiated with a Hold at Needham

Ultragenyx ($RARE) initiated with a Neutral at UBS, Target: $16

Vail Resorts ($MTN) initiated with a Market Perform at Citizens

Versant Media ($VSNT) initiated with an Equal Weight at Morgan Stanley, Target: $38

Viking Therapeutics ($VKTX) initiated with a Buy at UBS, Target: $94

Viper Energy ($VNOM) initiated with a Sector Outperform at Scotiabank, Target: $54

Warner Music Group ($WMG) initiated with a Buy at StoneX

Wave Life Sciences ($WVE) initiated with a Buy at UBS, Target: $11

York Space Systems ($YSS) initiated with a Neutral at Piper Sandler, Target: $9

Position: TheStreet Pro Portfolio is long BAC, NFLX 

Upside, Downside Movers in the Morning

Avatar photo Doug Kass on September 28, 2026

Upside

– $KOD +60% (pivotal Phase 3 DAYBREAK wet-AMD trial met its primary noninferiority endpoints, with most patients reaching a 24-week dosing interval)

– $ARAY +39% (agrees to explore integrating Samsung NeuroLogica volumetric imaging technology with the CyberKnife platform)

– $MEDS +28% (launches a GLP-1 care app offering telehealth consultations and access to branded medications)

– $WBUY +27% (first-half revenue nearly doubled, gross profit rose 132% and the net loss narrowed)

– $MTEK +21% (receives a record $10 million order for advanced video systems on next-generation airborne defense platforms)

– $AMPX +12% (wins a Defense Department grant of up to $75 million for domestic high-energy-density battery production, with about $22 million obligated initially)

– $SRFM +7.1% (selected as a participating airspace user in the FAA SMART program)

– $NTES +4.6% (no clear fresh catalyst identified; unusually large, liquid premarket move)

– $SM +2.6%, FRO +2.9%, APA +2.5%, OXY +1.7%, XOM +1.5%, CVX +1.5% (energy names rise as crude advances after the US rejected Iran’s conditions for reopening the Strait of Hormuz)

– $CF +2.4% (Rothschild Redburn upgrades to Neutral from Sell, citing a tighter nitrogen-market outlook)

Downside

– $GFI -13% (confirms a rejected A$27-per-share cash-and-stock proposal for Northern Star that would leave target holders owning about 33% of the combined company)

– $MNOV -12% (Phase 2 trial failed to show a statistically significant triglyceride benefit versus placebo at Week 24)

– $AU -5.6%, AG -4.5%, CDE -5.1%, HL -4.9%, EGO -4.6%, NEM -4.0% (precious-metals miners fall as gold and silver tumble on a stronger dollar, rising yields and increased Fed rate-hike expectations)

– $FCX -3.3%, SCCO -3.4%, HBM -3.8% (base-metal miners fall as the stronger dollar and rising yields pressure commodity prices)

– $META -2.7% (pulls back after last week’s sharp AI-led rally as rising Treasury yields pressure megacap growth stocks)

– $BE -2.6%, GLW -2.0%, MOD -3.0% (data-center infrastructure names retreat in the higher-yield risk-off tape)

– $CRCL -2.0% (crypto-linked shares weaken as Bitcoin falls about 2%)

– $TTMI -1.8%, CRDO -2.5%, SKHY -3.3%, INTC -2.4%, ARM -2.1%, SNDK -2.7% (high-beta chip and memory names retreat as oil-driven inflation fears lift Treasury yields and pressure the Nasdaq tape)

Upside, Downside Movers in the Morning

Avatar photo Doug Kass on September 23, 2026

Source: TradeTheNews

Upside

– $VTGN +59.5% (extends the prior-session rally after preliminary PALISADE-4 open-label extension data for fasedienol in social anxiety disorder)

– $GRML +24.0% (no clear fresh catalyst identified; exceptionally heavy-volume small-cap move)

– $WOR +15.5% (Q1 beat as stronger Building Products results and data-center demand lifted performance)

– $TLSI +15.0% (FDA grants 510(k) clearance for the TriNav Advance drug-delivery device)

– $IONQ +13.0% (demonstrates an end-to-end real-time quantum error-correction decoder running on a standard CPU)

– $CBRL +9.0% (Q4 profit beat and FY27 EBITDA outlook pointed to a sharp recovery despite lower sales)

– $QUBT +4.0% (quantum-computing sympathy following IONQ’s error-correction milestone)

– $CART +3.0% (expands its AI-shopping partnership network)

– $APH +3.0% (Bernstein initiates coverage at Outperform)

Downside

– $JAGX -48.0% (reverses sharply after the prior session’s roughly twelvefold FDA-fee-waiver-driven surge)

– $INNV -8.5% (10M-share secondary offering by selling stockholders creates a near-term stock overhang)

– $VOYG -7.5% ($350M convertible-senior-notes offering raises dilution concerns)

– $ASTH -7.5% (no clear fresh catalyst identified; renewed selling follows the recent short report questioning accounting estimates)

– $BMEA -7.0% (launches an underwritten common-stock and pre-funded-warrant offering)

– $AU -4.5%, GFI -4.5%, AG -3.0%, NEM -2.0% (precious-metals miners fall as gold and silver prices retreat)

– $BABA -3.0% (China ADR weakness ahead of the U.S.-China summit as mainland equities decline)

– $APP -2.5% (extends the AI-disruption selloff on concern consumer agents could pressure ad-tech economics)